StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Legal & Product Liability Provisions by Year

Legal & Product Liability Provisions ($M)

Novartis Legal & Product Liability Provisions: $147M in FY2025, down 10.4% from a year earlier.

Latest, FY2025
147
Period ended Dec 31, 2025
Change on a year earlier
-10.4%
164 in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Novartis Form 20-F (0001114448-26-000004) ↗

Reported in Form 20-F Note 20 (Provisions).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLegal & Product Liability Provisions ($M)Year on yearSource
FY2025Dec 31, 2025147-10.4%Novartis Form 20-F (0001114448-26-000004) ↗
FY2024Dec 31, 2024164+32.3%Novartis Form 20-F (0001114448-26-000004) ↗
FY2023Dec 31, 2023124-82.3%Novartis Form 20-F (0001114448-26-000004) ↗
FY2022Dec 31, 2022702+76.8%Novartis Form 20-F (0001114448-26-000004) ↗
FY2021Dec 31, 2021397-18.5%Novartis Form 20-F (0001370368-25-000004) ↗
FY2020Dec 31, 2020487-64.4%Novartis Form 20-F (0001370368-24-000004) ↗
FY2019Dec 31, 20191,369+302.6%Novartis Form 20-F/A (0001370368-23-000048) ↗
FY2018Dec 31, 2018340-3.1%Novartis Form 20-F (0001370368-22-000010) ↗
FY2017Dec 31, 2017351-11.1%Novartis Form 20-F (0001370368-21-000006) ↗
FY2016Dec 31, 2016395-66.9%Novartis Form 20-F (0001370368-20-000003) ↗
FY2015Dec 31, 20151,194–Novartis Form 20-F (0001370368-19-000002) ↗

Breakdown

What makes up legal & Product Liability Provisions

Cite this data

StockData. (2026). Novartis Legal & Product Liability Provisions ($M), annual FY2015–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/prov-legal-ending

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.